| Histology (ICD-O) (2) | All Races | Asian/Other | Black | Hispanic | White | |||||||
| Cases | % | Cases | % | Cases | % | Cases | % | Cases | % | |||
| TOTAL | 84,176 | 100.0 | 4,162 | 100.0 | 4,642 | 100.0 | 7,869 | 100.0 | 66,772 | 100.0 | ||
| Carcinoma | 83,788 | 99.5 | 4,137 | 99.4 | 4,623 | 99.6 | 7,812 | 99.3 | 66,504 | 99.6 | ||
| Epidermoid carcinoma (8051-8130) | 40 | 0.1 | 0 | 0.0 | 4 | 0.1 | 6 | 0.1 | 30 | 0.0 | ||
| Adenocarcinoma | 80,775 | 96.0 | 3,981 | 95.7 | 4,342 | 93.5 | 7,372 | 93.7 | 64,406 | 96.5 | ||
| Adenocarcinoma, NOS (8140) | 2,188 | 2.6 | 98 | 2.4 | 178 | 3.8 | 234 | 3.0 | 1,647 | 2.5 | ||
| Tubular adenocarcinoma (8211) | 1,033 | 1.2 | 20 | 0.5 | 28 | 0.6 | 61 | 0.8 | 913 | 1.4 | ||
| Infiltrating duct carcinoma, NOS (8500) | 60,283 | 71.6 | 3,058 | 73.5 | 3,218 | 69.3 | 5,576 | 70.9 | 47,944 | 71.8 | ||
| Scirrhous adenocarcinoma (8141) | 176 | 0.2 | 5 | 0.1 | 14 | 0.3 | 23 | 0.3 | 134 | 0.2 | ||
| Mucinous adenocarcinoma and mucin-producing adenocarcinoma (8480,8481) | 2,047 | 2.4 | 134 | 3.2 | 119 | 2.6 | 177 | 2.3 | 1,590 | 2.4 | ||
| Comedocarcinoma (8501) | 2,302 | 2.7 | 193 | 4.6 | 165 | 3.6 | 255 | 3.2 | 1,677 | 2.5 | ||
| Lobular carcinoma (8520,8521) | 6,077 | 7.2 | 158 | 3.8 | 221 | 4.8 | 404 | 5.1 | 5,244 | 7.9 | ||
| Infiltrating duct and lobular carcinoma (8522) | 3,753 | 4.5 | 145 | 3.5 | 141 | 3.0 | 305 | 3.9 | 3,131 | 4.7 | ||
| Inflammatory carcinoma (8530) | 1,149 | 1.4 | 62 | 1.5 | 109 | 2.4 | 184 | 2.3 | 794 | 1.2 | ||
| Paget's disease (8540-8543) | 790 | 0.9 | 38 | 0.9 | 64 | 1.4 | 71 | 0.9 | 602 | 0.9 | ||
| Papillary adenocarcinoma (8050,8260,8503) | 523 | 0.6 | 43 | 1.0 | 55 | 1.2 | 54 | 0.7 | 366 | 0.6 | ||
| Adenoid cystic/cribriform carcinoma (8200,8201) | 166 | 0.2 | 13 | 0.3 | 9 | 0.2 | 7 | 0.1 | 136 | 0.2 | ||
| Other adenocarcinoma | 288 | 0.3 | 14 | 0.3 | 21 | 0.5 | 21 | 0.3 | 228 | 0.3 | ||
| Other specific carcinoma | 1,505 | 1.8 | 86 | 2.1 | 164 | 3.5 | 249 | 3.2 | 999 | 1.5 | ||
| Medullary carcinoma (8510,8512) | 1,439 | 1.7 | 85 | 2.0 | 161 | 3.5 | 243 | 3.1 | 943 | 1.4 | ||
| Other specific carcinoma | 66 | 0.1 | 1 | 0.0 | 3 | 0.1 | 6 | 0.1 | 56 | 0.1 | ||
| Unspecified carcinoma | 1,468 | 1.7 | 70 | 1.7 | 113 | 2.4 | 185 | 2.4 | 1,069 | 1.6 | ||
| Carcinoma, NOS (8010,8011) | 1,376 | 1.6 | 64 | 1.5 | 104 | 2.2 | 172 | 2.2 | 1,006 | 1.5 | ||
| Undifferentiated carcinoma (8012-8022) | 92 | 0.1 | 6 | 0.1 | 9 | 0.2 | 13 | 0.2 | 63 | 0.1 | ||
| Sarcoma | 236 | 0.3 | 18 | 0.4 | 4 | 0.1 | 45 | 0.6 | 167 | 0.3 | ||
| Phyllodes tumor (9020) | 152 | 0.2 | 16 | 0.4 | 3 | 0.1 | 31 | 0.4 | 100 | 0.2 | ||
| Hemangiosarcoma (9120-9126,9170) | 31 | 0.0 | 0 | 0.0 | 0 | 0.0 | 3 | 0.0 | 28 | 0.0 | ||
| Other sarcoma | 53 | 0.1 | 2 | 0.1 | 1 | 0.0 | 11 | 0.1 | 39 | 0.1 | ||
| Other specified neoplasm | 24 | 0.0 | 0 | 0.0 | 3 | 0.1 | 3 | 0.0 | 18 | 0.0 | ||
| Unspecified neoplasm (8000-8004) | 128 | 0.2 | 7 | 0.2 | 12 | 0.3 | 9 | 0.1 | 83 | 0.1 | ||
Source: California Cancer Registry, November 1994. Excludes lymphohematopoietic neoplasms of the breast (ICD-O, Field Trial edition, histology codes 9590-9970) (2).
1 Race/ethnicity categories are mutually exclusive. Persons of Hispanic ethnicity are identified by medical record and/or surname, and may be of any race. Persons of unknown race/ethnicity are excluded from race-specific data.
2 Numbers in parentheses are ICD-O, Field Trial edition, histology codes (2). Where not specified, groups are as defined by Berg (11). NOS=not otherwise specified.
Return to Table of Contents
Return to Chapter 5
Return to Table 5.7
Go to Table 5.9